These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26430074)

  • 21. Identification of New Synthetic Cannabinoid ADB-CHMINACA (MAB-CHMINACA) Metabolites in Human Hepatocytes.
    Carlier J; Diao X; Sempio C; Huestis MA
    AAPS J; 2017 Mar; 19(2):568-577. PubMed ID: 28070717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22.
    Diao X; Scheidweiler KB; Wohlfarth A; Pang S; Kronstrand R; Huestis MA
    AAPS J; 2016 Mar; 18(2):455-64. PubMed ID: 26810398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of metabolites of the new synthetic cannabinoid CUMYL-4CN-BINACA in authentic urine samples and human liver microsomes using high-resolution mass spectrometry.
    Öztürk YE; Yeter O; Öztürk S; Karakus G; Ates I; Buyuk Y; Yurdun T
    Drug Test Anal; 2018 Mar; 10(3):449-459. PubMed ID: 28691766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites.
    Diao X; Huestis MA
    Front Chem; 2019; 7():109. PubMed ID: 30886845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic In Vitro Metabolic Profiling of the OXIZID Synthetic Cannabinoids BZO-4en-POXIZID, BZO-POXIZID, 5F-BZO-POXIZID, BZO-HEXOXIZID and BZO-CHMOXIZID.
    Watanabe S; Baginski S; Iwai T; Matsushita R; Takatsu M; Nakanishi T; Lindbom K; Mckenzie C; Vikingsson S; Kronstrand R; Gréen H; Seto Y
    J Anal Toxicol; 2023 May; 47(5):455-463. PubMed ID: 36857377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.
    Watanabe S; Kuzhiumparambil U; Nguyen MA; Cameron J; Fu S
    AAPS J; 2017 Jul; 19(4):1148-1162. PubMed ID: 28455676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic patterns of JWH-210, RCS-4, and THC in pig urine elucidated using LC-HR-MS/MS: Do they reflect patterns in humans?
    Schaefer N; Helfer AG; Kettner M; Laschke MW; Schlote J; Ewald AH; Meyer MR; Menger MD; Maurer HH; Schmidt PH
    Drug Test Anal; 2017 Apr; 9(4):613-625. PubMed ID: 27328899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation.
    Wohlfarth A; Scheidweiler KB; Pang S; Zhu M; Castaneto M; Kronstrand R; Huestis MA
    Drug Test Anal; 2016 Aug; 8(8):779-91. PubMed ID: 26331297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic characteristic profiling of 1-amino-3,3-dimethyl-1-oxobutan-2-yl-derived indole and indazole synthetic cannabinoids in vitro.
    Luo X; Huang Z; Huang K; Liu X; Yang N; Luo Q
    J Pharm Biomed Anal; 2024 Nov; 250():116385. PubMed ID: 39116582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB-CHMINACA via human liver microsome incubation and high-resolution mass spectrometry.
    Presley BC; Logan BK; Jansen-Varnum SA
    Drug Test Anal; 2019 Aug; 11(8):1264-1276. PubMed ID: 31108568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro metabolism of the synthetic cannabinoids CUMYL-PINACA, 5F-CUMYL-PINACA, CUMYL-4CN-BINACA, 5F-CUMYL-P7AICA and CUMYL-4CN-B7AICA.
    Staeheli SN; Poetzsch M; Veloso VP; Bovens M; Bissig C; Steuer AE; Kraemer T
    Drug Test Anal; 2018 Jan; 10(1):148-157. PubMed ID: 28885775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of the synthetic cannabinoid 5F-PY-PICA by human and rat hepatocytes and identification of biliary analytical targets by directional efflux in sandwich-cultured rat hepatocytes using UHPLC-HR-MS/MS.
    Mardal M; Annaert P; Noble C; Oorts M; Linnet K
    J Pharm Biomed Anal; 2018 Feb; 149():296-307. PubMed ID: 29128830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards.
    Baginski SR; Rautio T; Nisbet LA; Lindbom K; Wu X; Dahlén J; McKenzie C; Gréen H
    J Anal Toxicol; 2023 Dec; 47(9):826-834. PubMed ID: 37747838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of urinary metabolites of the synthetic cannabinoid 5F-CUMYL-P7AICA in human casework.
    Staeheli SN; Steuer AE; Kraemer T
    Forensic Sci Int; 2019 Jan; 294():76-79. PubMed ID: 30471536
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Carlier J; Diao X; Wohlfarth A; Scheidweiler K; Huestis MA
    Curr Neuropharmacol; 2017 Jul; 15(5):682-691. PubMed ID: 29403341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.
    Stalberga D; Ingvarsson S; Bessa G; Maas L; Vikingsson S; Persson M; Norman C; Gréen H
    Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):263-280. PubMed ID: 36544361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolite Profiling of Ortho-, Meta- and Para-Fluorofentanyl by Hepatocytes and High-Resolution Mass Spectrometry.
    Gundersen POM; Åstrand A; Gréen H; Josefsson M; Spigset O; Vikingsson S
    J Anal Toxicol; 2020 Mar; 44(2):140-148. PubMed ID: 31788682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.